Barclays PLC has disclosed its position in HIPGNOSIS SONGS FUND LTD, revealing ownership and control of 31,914,405 ordinary shares, representing 2.64% of the total shares. Additionally, the disclosure includes cash-settled derivatives amounting to 3 shares and stock-settled derivatives with no holdings. The dealings by Barclays PLC on July 1, 2024, involved the purchase of 31,914,408 ordinary shares and the sale of 756,747 ordinary shares. The purchase prices ranged from 1.0211 GBP to 1.0260 GBP, while the sale prices ranged from 1.0223 GBP to 1.0261 GBP.
Barclays PLC also engaged in cash-settled derivative transactions, including decreasing short positions for 973 reference securities and increasing short positions for 153,777 reference securities. Moreover, they opened a long position for 704,205 reference securities and closed a long position for 41,438 reference securities in SWAP transactions. The disclosure does not indicate any stock-settled derivative transactions, including options.
The disclosure further states that there are no indemnity or other dealings arrangements, agreements, arrangements, or understandings relating to options or derivatives. It also confirms that no supplemental Form 8 (Open Positions) is attached to the disclosure. The contact name provided for the disclosure is Large Holdings Regulatory Operations, with no telephone number listed.
This disclosure by Barclays PLC provides a comprehensive overview of their interests, short positions, and dealings in HIPGNOSIS SONGS FUND LTD, offering transparency regarding their holdings and transactions related to the company's securities.